dr. brufsky on anastrozole versus tamoxifen in dcis
Published 9 years ago • 1.2K plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
2:15
dr. patricia ganz on anastrozole versus tamoxifen side effects in dcis patients
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
1:04
dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
-
4:55
anastrozole (a) vs tamoxifen (tam) in postmenopausal patients with dcis
-
3:39
comparable outcomes, different toxicities with anastrozole, tamoxifen in dcis | ivana sestak
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
3:04
12-year results of anastrozole vs tamoxifen for breast cancer prevention
-
1:06
dr. brufsky on challenges in breast cancer
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
1:29
dr brufsky on the unique design of the allogeneic sv-br-1-gm vaccine in metastatic breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
2:20
dr. brufsky on choosing when to do a multiparameter genomic assay
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:31
dr. brufsky discusses the tnacity trial
-
1:15
dr. brufsky on reducing the cost of care in breast oncology